Found: 23
Select item for more details and to access through your institution.
Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Diabetic Ketoacidosis and Related Events in the Canaglif lozin Type 2 Diabetes Clinical Program.
- Published in:
- Diabetes Care, 2015, v. 38, n. 9, p. 1680, doi. 10.2337/dc15-1251
- By:
- Publication type:
- Article
A Randomized Trial of Lifestyle Modification and Taranabant for Maintaining Weight Loss Achieved With a Low-Calorie Diet.
- Published in:
- Obesity (19307381), 2010, v. 18, n. 12, p. 2301, doi. 10.1038/oby.2010.67
- By:
- Publication type:
- Article
The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The Globalization of Risk and Risk Perception. Why We Need a New Model of Risk Communication for Vaccines.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1053, doi. 10.2165/11635880-000000000-00000
- By:
- Publication type:
- Article
Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic Arthritis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist.
- Published in:
- AAPS Journal, 2010, v. 12, n. 4, p. 537, doi. 10.1208/s12248-010-9212-2
- By:
- Publication type:
- Article
Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0282267
- By:
- Publication type:
- Article
NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine.
- Published in:
- Obesity (19307381), 2007, v. 15, n. 8, p. 2027, doi. 10.1038/oby.2007.242
- By:
- Publication type:
- Article
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Fat and Energy Partitioning: Longitudinal Observations in Leptin-treated Adults Homozygous for a Lep Mutation<sup>*</sup>.
- Published in:
- Obesity (19307381), 2006, v. 14, n. 2, p. 258, doi. 10.1038/oby.2006.33
- By:
- Publication type:
- Article
Efficacy and Safety of Intranasal Peptide YY<sub>3–36 </sub>for Weight Reduction in Obese Adults.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 5, p. 1754, doi. 10.1210/jc.2006-1806
- By:
- Publication type:
- Article
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924
- By:
- Publication type:
- Article
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R): A randomized, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 387, doi. 10.1111/dom.12829
- By:
- Publication type:
- Article
WHO has been reformed: How can it be empowered to lead global public health?
- Published in:
- Global Social Policy, 2020, v. 20, n. 3, p. 393, doi. 10.1177/1468018120966656
- By:
- Publication type:
- Article
Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases.
- Published in:
- Rheumatology, 2016, v. 55, p. ii43, doi. 10.1093/rheumatology/kew346
- By:
- Publication type:
- Article
Financial Technology Investment and Poverty Reduction in Nigeria.
- Published in:
- ANWESH: International Journal of Management & Information Technology, 2024, v. 9, n. 1, p. 17
- By:
- Publication type:
- Article
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 10, p. 1353, doi. 10.1093/cid/ciw601
- By:
- Publication type:
- Article
CB1 receptor inverse agonist pharmacotherapy for metabolic disorders.
- Published in:
- Drug Development Research, 2009, v. 70, n. 8, p. 566, doi. 10.1002/ddr.20335
- By:
- Publication type:
- Article
Assessment of Disaster Training Needs for Physicians and Other Health Professionals Serving Vulnerable Populations in Hawai'i.
- Published in:
- 2008
- By:
- Publication type:
- Excerpt